Related Experiment Video
Updated: Dec 20, 2025

A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics
Published on: September 22, 2011
Sensitive, Rapid, Robust, and Reproducible Workflow for Host Cell Protein Profiling in Biopharmaceutical Process
1CMC Analytical, GlaxoSmithKline, 1250 S. Collegeville Road, Collegeville, Pennsylvania 19426, United States.
A new, rapid workflow for detecting host cell proteins (HCPs) in biopharmaceuticals has been developed. This method enables high-throughput analysis, improving biopharmaceutical production and risk assessment for drug safety.
Area of Science:
- Biopharmaceutical Manufacturing
- Analytical Chemistry
- Proteomics
Background:
- Host cell proteins (HCPs) are critical impurities in biopharmaceutical production.
- Regulatory agencies require HCP identification and quantification for risk assessment.
- Existing HCP detection methods can be time-consuming, limiting process development integration.
Purpose of the Study:
- To develop a sensitive, robust, and reproducible workflow for HCP detection and quantification.
- To significantly reduce the turnaround time for HCP analysis.
- To enable high-throughput HCP profiling for biopharmaceutical process development.
Main Methods:
- Utilized an Evosep ONE LC system coupled to an Orbitrap Fusion Lumos mass spectrometer.
- Developed a rapid workflow for HCP detection and quantification.
- Analyzed NIST monoclonal antibody reference material.
Main Results:
- Achieved significantly shorter turnaround times compared to previous methods.
- Enabled high-throughput analysis with a capacity of 60 samples per day.
- Detected the largest number of HCPs reported to date in the NIST reference material, demonstrating improved performance and throughput.
Conclusions:
- The developed HCP workflow is sensitive, robust, and reproducible.
- The rapid nature of the workflow allows for integration into biopharmaceutical process development.
- This method facilitates better risk assessment and optimization of biopharmaceutical production by enabling rapid measurement and clearance tracking of HCPs.
More Related Videos
09:45Author Spotlight: Detecting Low-Abundant Host Cell Proteins in Drug Products Using Enrichment Beads and Limited Digestion
Published on: January 19, 2024
11:09An HS-MRM Assay for the Quantification of Host-cell Proteins in Protein Biopharmaceuticals by Liquid Chromatography Ion Mobility QTOF Mass Spectrometry
Published on: April 17, 2018